ALBIGES v. ENDO INTERNATIONAL PLC et al
Case Number:
2:20-cv-07536
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
August 17, 2022
Endo Beats Investors' Opioid Crisis Class Action, For Good
A New Jersey federal judge on Wednesday tossed a proposed class action accusing Endo International PLC — which yesterday filed for Chapter 11 protection — of misleading investors about its role in the opioid crisis, saying the shareholders haven't shown the company's statements were misleading or caused their losses.
-
September 01, 2021
Endo Beats Investors' Opioid Crisis Class Suit, For Now
A New Jersey federal judge has tossed a proposed class action against Endo International PLC over claims it misled investors about its role in the opioid crisis, finding the investors failed to show how the drugmaker defrauded them.
-
September 28, 2020
Pomerantz To Lead Endo Investor Suit Over Opioid Crisis
A New Jersey federal judge on Monday signed off on a lead plaintiff and lead counsel Pomerantz LLP in a proposed class action against Endo International PLC over claims the drugmaker misled investors about its role in the opioid crisis.
-
August 19, 2020
4 Firms Vie To Lead Endo Investor Suit Over Opioid Crisis
Glancy Prongay & Murray LLP, Pomerantz LLP, Levi & Korsinsky LLP and Bragar Eagel & Squire PC have launched competing bids to steer a proposed class action against Endo International PLC in New Jersey federal court over claims the drugmaker misled investors about its role in the opioid crisis.
-
June 22, 2020
Investor Says Endo Lied About Role In NY Opioid Crisis
An Endo International PLC investor launched a proposed class action Monday claiming the drugmaker's stock dropped nearly 15% after allegations surfaced about the company's role in New York's opioid crisis, unearthing a purported cover-up that left shareholders in the dark.